iridium has been researched along with naphthalimides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Liu, Z; Ma, W; Tian, Z; Xia, X; Xu, Z; Zhang, S; Zhang, Y | 1 |
1 other study(ies) available for iridium and naphthalimides
| Article | Year |
|---|---|
Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Iridium; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Naphthalimides; Neoplasms; Ruthenium | 2019 |